Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
CBT 200 Climbs For Second Week In A Row. More details...
CBT 200 Takes A Header. More details...
No Real Breakthrough But A Big Shift. More details...
CBT 200 Slips 3 Points Lower. More details...
CBT 200 Recovers From Early Drop, Gains 10 Points. More...
CBT 200 Slips 12 Points Lower. More details...
Six Drugs In The Clinic And A Pile Of Cash. More details...
CBT 200 Drops 3.3%. More details...
CBT 200 Falls 1%. More details...
Company Develops Antibiotics. More details...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
